US Stock MarketDetailed Quotes

AbCellera Biologics (ABCL)

Watchlist
  • 4.113
  • -0.067-1.60%
Close Jan 16 16:00 ET
  • 4.130
  • +0.017+0.41%
Post 16:18 ET
1.23BMarket Cap-7.22P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AbCellera Biologics (ABCL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
37.62%8.96M
133.29%17.08M
-57.45%4.24M
-24.17%28.83M
-44.98%5.05M
-1.39%6.51M
-27.18%7.32M
-18.36%9.95M
-92.17%38.03M
-57.40%9.18M
Operating revenue
37.62%8.96M
133.29%17.08M
-57.45%4.24M
-24.17%28.83M
-44.98%5.05M
-1.39%6.51M
-27.18%7.32M
-18.36%9.95M
-92.17%38.03M
-57.40%9.18M
Cost of revenue
0
0
Gross profit
-24.17%28.83M
-90.92%38.03M
Operating expense
-14.66%82.5M
-35.39%62.98M
1.90%62.74M
26.39%329.98M
3.35%74.26M
64.81%96.68M
71.39%97.47M
-16.45%61.57M
36.03%261.08M
28.10%71.86M
Selling and administrative expenses
12.01%24.96M
-5.75%21.99M
-7.96%19.07M
13.72%85.49M
0.47%19.16M
24.92%22.28M
20.48%23.33M
9.58%20.72M
12.62%75.18M
21.44%19.07M
-Selling and marketing expense
-7.30%2.91M
-4.05%3.01M
-15.54%2.84M
-9.88%12.78M
1.42%3.14M
-9.60%3.14M
-18.35%3.14M
-10.77%3.37M
25.82%14.18M
15.20%3.1M
-General and administrative expense
15.17%22.05M
-6.02%18.98M
-6.49%16.23M
19.20%72.71M
0.29%16.02M
33.25%19.15M
30.09%20.19M
14.66%17.35M
9.94%61M
22.74%15.97M
Research and development costs
34.32%55.03M
-4.19%39.21M
8.17%42.5M
-4.78%167.26M
-5.24%46.08M
8.05%40.97M
12.21%40.93M
-25.38%39.29M
62.83%175.66M
72.14%48.62M
Depreciation amortization depletion
-85.79%5.25M
-85.02%5.47M
10.05%5.33M
272.41%90.85M
66.73%12.57M
543.75%36.92M
551.02%36.52M
-12.15%4.84M
-12.38%24.4M
-45.46%7.54M
-Depreciation and amortization
-85.79%5.25M
-85.02%5.47M
10.05%5.33M
272.41%90.85M
66.73%12.57M
543.75%36.92M
551.02%36.52M
-12.15%4.84M
-12.38%24.4M
-45.46%7.54M
Other operating expenses
21.83%-2.73M
-11.54%-3.69M
-26.81%-4.15M
3.78%-13.62M
-4.98%-3.54M
-23.44%-3.49M
27.67%-3.31M
2.93%-3.28M
-34.12%-14.16M
-101.55%-3.38M
Operating profit
18.43%-73.55M
49.09%-45.89M
-13.34%-58.51M
-35.01%-301.15M
-10.42%-69.21M
-73.20%-90.17M
-92.56%-90.14M
16.07%-51.62M
-198.23%-223.05M
-73.61%-62.68M
Net non-operating interest income expense
-29.55%6.77M
-22.54%7.59M
-22.59%8.05M
-8.93%38.47M
-20.98%8.67M
-10.59%9.6M
-9.07%9.8M
6.58%10.4M
162.75%42.25M
29.50%10.97M
Non-operating interest income
-29.55%6.77M
-22.54%7.59M
-22.59%8.05M
-8.93%38.47M
-20.98%8.67M
-10.59%9.6M
-9.07%9.8M
6.58%10.4M
162.75%42.25M
29.50%10.97M
Other net income (expense)
-111.06%-1.98M
-93.91%1.96M
-65.34%-2.53M
819.10%62.28M
341.53%13.71M
776.69%17.94M
1,732.28%32.16M
-142.55%-1.53M
267.52%6.78M
182.19%3.11M
Other non- operating income (expenses)
-111.06%-1.98M
-93.91%1.96M
-65.34%-2.53M
819.10%62.28M
341.53%13.71M
776.69%17.94M
1,732.28%32.16M
-142.55%-1.53M
267.52%6.78M
182.19%3.11M
Income before tax
-9.80%-68.77M
24.58%-36.34M
-23.95%-52.98M
-15.15%-200.4M
3.65%-46.83M
-59.47%-62.63M
-26.79%-48.19M
11.22%-42.75M
-172.79%-174.03M
-54.72%-48.6M
Income tax
-1.08%-11.65M
85.64%-1.62M
-244.55%-7.36M
-35.85%-37.54M
-769.08%-12.62M
-8.05%-11.53M
-50.58%-11.26M
73.41%-2.14M
-134.29%-27.63M
4.41%-1.45M
Net income
-11.76%-57.12M
5.97%-34.73M
-12.34%-45.62M
-11.24%-162.86M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
Net income continuous Operations
-11.76%-57.12M
5.97%-34.73M
-12.34%-45.62M
-11.24%-162.86M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
Minority interest income
Net income attributable to the parent company
-11.76%-57.12M
5.97%-34.73M
-12.34%-45.62M
-11.24%-162.86M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.76%-57.12M
5.97%-34.73M
-12.34%-45.62M
-11.24%-162.86M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-192.35%-146.4M
-57.73%-47.15M
Basic earnings per share
-11.76%-0.19
7.69%-0.12
-7.14%-0.15
-7.84%-0.55
35.29%-0.11
-70.00%-0.17
-18.18%-0.13
0.00%-0.14
-191.07%-0.51
-70.00%-0.17
Diluted earnings per share
-11.76%-0.19
7.69%-0.12
-7.14%-0.15
-7.84%-0.55
35.29%-0.11
-70.00%-0.17
-18.18%-0.13
0.00%-0.14
-202.00%-0.51
-70.00%-0.17
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 37.62%8.96M133.29%17.08M-57.45%4.24M-24.17%28.83M-44.98%5.05M-1.39%6.51M-27.18%7.32M-18.36%9.95M-92.17%38.03M-57.40%9.18M
Operating revenue 37.62%8.96M133.29%17.08M-57.45%4.24M-24.17%28.83M-44.98%5.05M-1.39%6.51M-27.18%7.32M-18.36%9.95M-92.17%38.03M-57.40%9.18M
Cost of revenue 00
Gross profit -24.17%28.83M-90.92%38.03M
Operating expense -14.66%82.5M-35.39%62.98M1.90%62.74M26.39%329.98M3.35%74.26M64.81%96.68M71.39%97.47M-16.45%61.57M36.03%261.08M28.10%71.86M
Selling and administrative expenses 12.01%24.96M-5.75%21.99M-7.96%19.07M13.72%85.49M0.47%19.16M24.92%22.28M20.48%23.33M9.58%20.72M12.62%75.18M21.44%19.07M
-Selling and marketing expense -7.30%2.91M-4.05%3.01M-15.54%2.84M-9.88%12.78M1.42%3.14M-9.60%3.14M-18.35%3.14M-10.77%3.37M25.82%14.18M15.20%3.1M
-General and administrative expense 15.17%22.05M-6.02%18.98M-6.49%16.23M19.20%72.71M0.29%16.02M33.25%19.15M30.09%20.19M14.66%17.35M9.94%61M22.74%15.97M
Research and development costs 34.32%55.03M-4.19%39.21M8.17%42.5M-4.78%167.26M-5.24%46.08M8.05%40.97M12.21%40.93M-25.38%39.29M62.83%175.66M72.14%48.62M
Depreciation amortization depletion -85.79%5.25M-85.02%5.47M10.05%5.33M272.41%90.85M66.73%12.57M543.75%36.92M551.02%36.52M-12.15%4.84M-12.38%24.4M-45.46%7.54M
-Depreciation and amortization -85.79%5.25M-85.02%5.47M10.05%5.33M272.41%90.85M66.73%12.57M543.75%36.92M551.02%36.52M-12.15%4.84M-12.38%24.4M-45.46%7.54M
Other operating expenses 21.83%-2.73M-11.54%-3.69M-26.81%-4.15M3.78%-13.62M-4.98%-3.54M-23.44%-3.49M27.67%-3.31M2.93%-3.28M-34.12%-14.16M-101.55%-3.38M
Operating profit 18.43%-73.55M49.09%-45.89M-13.34%-58.51M-35.01%-301.15M-10.42%-69.21M-73.20%-90.17M-92.56%-90.14M16.07%-51.62M-198.23%-223.05M-73.61%-62.68M
Net non-operating interest income expense -29.55%6.77M-22.54%7.59M-22.59%8.05M-8.93%38.47M-20.98%8.67M-10.59%9.6M-9.07%9.8M6.58%10.4M162.75%42.25M29.50%10.97M
Non-operating interest income -29.55%6.77M-22.54%7.59M-22.59%8.05M-8.93%38.47M-20.98%8.67M-10.59%9.6M-9.07%9.8M6.58%10.4M162.75%42.25M29.50%10.97M
Other net income (expense) -111.06%-1.98M-93.91%1.96M-65.34%-2.53M819.10%62.28M341.53%13.71M776.69%17.94M1,732.28%32.16M-142.55%-1.53M267.52%6.78M182.19%3.11M
Other non- operating income (expenses) -111.06%-1.98M-93.91%1.96M-65.34%-2.53M819.10%62.28M341.53%13.71M776.69%17.94M1,732.28%32.16M-142.55%-1.53M267.52%6.78M182.19%3.11M
Income before tax -9.80%-68.77M24.58%-36.34M-23.95%-52.98M-15.15%-200.4M3.65%-46.83M-59.47%-62.63M-26.79%-48.19M11.22%-42.75M-172.79%-174.03M-54.72%-48.6M
Income tax -1.08%-11.65M85.64%-1.62M-244.55%-7.36M-35.85%-37.54M-769.08%-12.62M-8.05%-11.53M-50.58%-11.26M73.41%-2.14M-134.29%-27.63M4.41%-1.45M
Net income -11.76%-57.12M5.97%-34.73M-12.34%-45.62M-11.24%-162.86M27.44%-34.21M-78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M
Net income continuous Operations -11.76%-57.12M5.97%-34.73M-12.34%-45.62M-11.24%-162.86M27.44%-34.21M-78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M
Minority interest income
Net income attributable to the parent company -11.76%-57.12M5.97%-34.73M-12.34%-45.62M-11.24%-162.86M27.44%-34.21M-78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.76%-57.12M5.97%-34.73M-12.34%-45.62M-11.24%-162.86M27.44%-34.21M-78.63%-51.11M-20.97%-36.93M-1.25%-40.61M-192.35%-146.4M-57.73%-47.15M
Basic earnings per share -11.76%-0.197.69%-0.12-7.14%-0.15-7.84%-0.5535.29%-0.11-70.00%-0.17-18.18%-0.130.00%-0.14-191.07%-0.51-70.00%-0.17
Diluted earnings per share -11.76%-0.197.69%-0.12-7.14%-0.15-7.84%-0.5535.29%-0.11-70.00%-0.17-18.18%-0.130.00%-0.14-202.00%-0.51-70.00%-0.17
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.41%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.57%
4
Kingsoft Cloud
KC
+7.99%
5
United Microelectronics
UMC
+5.80%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -